期刊文献+

人甲胎蛋白时间分辨免疫荧光分析试剂盒的研制 被引量:9

Preparation of time-resolved fluoroimmunoassay kit for human alpha-fetoprotein detection
下载PDF
导出
摘要 目的研制人甲胎蛋白(hAFP)时间分辨免疫荧光分析(TRFIA)试剂盒.方法采用双抗体夹心法建立AFP TRFIA 试剂盒,对试剂盒的各项指标进行评价.结果试剂盒的可测范围为l~1 000 U/ml,灵敏度为0.17 U/ml,精密度良好,批内和批间的精密度分别为3.3%~5.9%,3.7%~6.5%.与CEA、CA12-5、CA19-9、CA15-3、白蛋白无交叉反应.稳定性试验表明试剂可以在4℃稳定1年,37℃稳定7 d.426份正常血清标本测试该试剂盒的正常参考值范围是0~12 U/ml.用本试剂盒与国外同类试剂盒同时检测60份血清标本,其相关系数为0.995.结论试剂盒各项指标(灵敏度、精密度、特异性、稳定性、准确度)均达到临床检测要求,可替代国外同类产品试剂盒. Objective To prepare time-resolved fluoroimmunoassay (TRFIA) kit for detecting human alpha-fetoprotein (hAFP). Methods Sandwich TRFIA kit for hAFP detection was developed using monoclonal antibody of anti-AFP. Results AFP-TRFIA kit was capable of detecting AFP within the range of 1-1 000 U/ml with sensitivity of 0.17 U/ml and without cross-reactivity with CEA, CA12-5, CA15-3, or CA19-9. The intra- and inter-assay coefficients of variation were (3.3-5.9)% and (3.7-6.5)%, respectively. The prepared AFP-TRFIA reagent could withstand preservation at 4 ℃ for 1 year and at 37 ℃ for 7 days with the cutoff value of 12 U/ml in healthy subjects (n=426). The correlation coefficient of the detection results between this kit and commercially available AFP kit (Wallac OY, Finland) for 60 blood samples was 0.995. Conclusion The prepared TRFIA kit for hAFP detection meets the demand of clinical application with good sensitivity, precision, specificity, stability and accuracy.
出处 《第一军医大学学报》 CSCD 北大核心 2005年第3期313-317,共5页 Journal of First Military Medical University
基金 广州市研究开发基地建设项目(2003U130021)~~
关键词 人甲胎蛋白(hAFP) 时间分辨免疫荧光分析(TRFIA) 试剂盒 human alpha-fetoprotein time-resolved fluoroimmunoassay reagent kit
  • 相关文献

参考文献9

  • 1Gillespie JR. Uversky VN. Structure and function ofα-fetoprotein:a biophysical overview[J ]. Biochem Biophys Acta,2000,1480:41-56.
  • 2Abelve GI. Alpha-fetoprotein as a marker of embryo-differentiation in a normal and human tissues[J]. Transplant Rev,1974,20:3-37.
  • 3Persson HP,Beller GA,Smith TW,et al. Screen for fetal malformations using ultrasound and measurements of alpha-fetoprotein in maternal serum [ J ]. Br Med,1983,286:747.
  • 4商健彪,李彦豪,刘方颖,曾庆乐,王江云,何晓峰,陈勇.肝细胞性肝癌^(18)F-FDGPET显像与血清甲胎蛋白的相关性研究[J].第一军医大学学报,2004,24(6):697-699. 被引量:18
  • 5Kobayashi M,Kimura H,Liao J,et al. Measurement of mouse urinary type Ⅳ collagen using time-resolved fluoroimmunoassay [J]. Anal Sci,2003,19(2):205-10.
  • 6Andoh T,Nagasawa H. Development of a time-resolved fluoroimmunoassay for insulins and its application to monitoring of insulin secretion induced by feeding in the barfin flounder,Verasper moseri [J ]. Gen Comp Endocrinol,2002,125(3):365-74.
  • 7Yamada H,Chiba H,Amano M,et al. Rainbow trout eyed-stage embryos demonstrate melatonin rhythms under light-dark conditions as measured by newly developed time-resloved fluoroimmunoassay [ J ]. Gen Comp Endocrinol,2002,125(1):41-6.
  • 8Kimura H,Suzui M,Nagao F,et al. Highly sensitive determination of plasma cytokines by time-resolved fluoroimmunoassay; effect of bicycle exercise on plasma level of interleukin-1 alpha (IL-1 alpha),tumor necrosis factor (TNF alpha),and interferon (IFN gamma )[J].Anal Sci,2001,17(5):593-7.
  • 9Ito K,Oda M,Tsuji,et al. Simultaneous determination of alphafetoprotein,human chorionic gonadotropin and estriol in serum of pregnant women by time-resolved fluoroimmunoassay [J]. Pharm Biomed Anal,1999,20(1-2):169-78.

二级参考文献19

  • 1王易伦,杨静华,何开跃,王国华.甲胎蛋白对肝癌细胞生长的影响 Ⅰ.人AFP对小鼠H_(22)腹水型肝癌细胞RNA合成的促进作用[J].中国肿瘤临床,1989,16(5):290-293. 被引量:8
  • 2Patz EF,Lowe VJ,HoffmanJM,et al.Focal pulmonary abnormalities:evaluation with 18F-fluorodexy glucose PET scanning [J].Radiology,1993,188(45):487-90.
  • 3Sazon DA,Santiago SM,Soohoo GW,et al.Fluowdexyglucose positron emission tomography in the detection and staging lung cancer[J].AmJRespir Crit Care Med,1996,153(1):417-21.
  • 4Adler LP,CroweJP,Kaisi AL,et al.Evaluation of breast mass and axillary lymph nodes with FDG-PET[J].Radiology,1987,148(54):365-77.
  • 5Okazumi S,Isono K,Enimoto K,et al.Evaluation of liver tumors using 18F-FDG PET characterization of tumor and assessment of effect oftreatment[J].JNucl Med,1992,33(9):333-9.
  • 6Magrath I,LitvakJ.Cancer in developing countries:opportunity and challenge[J].JNatl Cancer Inst,1993,85(17):862-73.
  • 7Higashi K,Veda Y,Yagishita M,et al.FDG PET measurement of proliferative potiential of non-small cell lung cancer [J].JNucl Med,2000,41(1):85-92.
  • 8Hawkins RA,Hohc H,GlaspyJ,et al.The role of positron emission tomography in oncology and other whole body application [J].Semin Nucl Med,1992,22(8):268-9.
  • 9Conti PS,Lilien DL,Hawley K,et al.PET and 18F-FDG in positron tomography for oncology:a clinical update [J].Nucl Med Biol,1996,23(12):717-35.
  • 10Crippa F,Gavazzi C,Bozzetti F,et al.The influence of blood glucose levels on 18F-FDG uptake in cancer:a PET study in liver metastases from colorectal carcinomas[J].Tumor,1997,83(4):748-52.

共引文献17

同被引文献120

引证文献9

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部